Global and United States Lyophilization Contract Manufacturing Services (CDMO) Market Report & Forecast 2024-2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Software
Publisher : MRA | Format : PDF
Global and United States Lyophilization Contract Manufacturing Services (CDMO) Market Report & Forecast 2024-2034
Lyophilization is a process that removes moisture from a product while preserving its original chemical properties. Also known as freeze drying, this process is used in the production of many products, such as pharmaceuticals, biologics, food additives, and nutraceuticals. Lyophilization helps to reduce spoilage and extend the shelf life of a product, making it more stable and easier to transport.Pharmaceutical companies use lyophilization to make lyophilized injections, eye drops, other sensitive drugs, and parenteral dosage forms that cannot be manufactured through traditional methods. In the biopharmaceutical industry, lyophilization is used to preserve proteins and peptides for long-term storage, giving unstable biologics the shelf life and stability for more widespread distribution and use.
Lyophilization contract manufacturing services are beneficial for pharmaceutical and biopharmaceutical companies who lack the necessary resources and expertise to produce their own lyophilized products. Lyophilization is a meticulous process, but with experienced professionals to help guide the way, an effective lyophilized drug can be produced in a short amount of time.
Market Analysis and InsightsGlobal and United States Lyophilization Contract Manufacturing Services (CDMO) Market
This report focuses on global and United States Lyophilization Contract Manufacturing Services (CDMO) market, also covers the segmentation data of other regions in regional level and county level.
The global Lyophilization Contract Manufacturing Services (CDMO) revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the review period (2023-2033).
In United States the Lyophilization Contract Manufacturing Services (CDMO) revenue is expected to grow from US$ million in 2023 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
The global key players of Lyophilization Contract Manufacturing Services (CDMO) include Thermo Fisher Scientific Inc., Ascendia Pharmaceuticals, PCI Pharma Services, Ellab, Lyophilization Technology,Inc., Lundbeck, LSNE Contract Manufacturing, Pfizer and Jubilant Pharmova, etc. The global five biggest players hold a share of % in 2023.
Global Lyophilization Contract Manufacturing Services (CDMO) Scope and Market Size
Lyophilization Contract Manufacturing Services (CDMO) market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Lyophilization Contract Manufacturing Services (CDMO) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For United States market, this report focuses on the Lyophilization Contract Manufacturing Services (CDMO) market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in United States.
Thermo Fisher Scientific Inc.
Ascendia Pharmaceuticals
PCI Pharma Services
Ellab
Lyophilization Technology,Inc.
Lundbeck
LSNE Contract Manufacturing
Pfizer
Jubilant Pharmova
CARBOGEN AMCIS
Lubrizol Life Science
Recipharm AB
Berkshire Sterile Manufacturing
AbbVie
Zenvision Pharma LLP
Eurofins
COC Farmaceutici
Leadgene Biomedical,Inc.
Liof Pharma
Argonaut Manufacturing Services
Societal CDMO
PharmTech
Oakwood Labs
IDT Biologika
EMCM
Segment by Type
Formulation&Process Development
Lyophilization
Clinical Supply Manufacturing
Commercial Manufacturing
Storage&Distribution
Analytical Services
Pharmaceutical Company
Biotechnology Company
Generic Company
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter 1Introduces Lyophilization Contract Manufacturing Services (CDMO) definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Lyophilization Contract Manufacturing Services (CDMO) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Lyophilization Contract Manufacturing Services (CDMO) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lyophilization Contract Manufacturing Services (CDMO) revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions
Lyophilization contract manufacturing services are beneficial for pharmaceutical and biopharmaceutical companies who lack the necessary resources and expertise to produce their own lyophilized products. Lyophilization is a meticulous process, but with experienced professionals to help guide the way, an effective lyophilized drug can be produced in a short amount of time.
Market Analysis and InsightsGlobal and United States Lyophilization Contract Manufacturing Services (CDMO) Market
This report focuses on global and United States Lyophilization Contract Manufacturing Services (CDMO) market, also covers the segmentation data of other regions in regional level and county level.
The global Lyophilization Contract Manufacturing Services (CDMO) revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the review period (2023-2033).
In United States the Lyophilization Contract Manufacturing Services (CDMO) revenue is expected to grow from US$ million in 2023 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
The global key players of Lyophilization Contract Manufacturing Services (CDMO) include Thermo Fisher Scientific Inc., Ascendia Pharmaceuticals, PCI Pharma Services, Ellab, Lyophilization Technology,Inc., Lundbeck, LSNE Contract Manufacturing, Pfizer and Jubilant Pharmova, etc. The global five biggest players hold a share of % in 2023.
Global Lyophilization Contract Manufacturing Services (CDMO) Scope and Market Size
Lyophilization Contract Manufacturing Services (CDMO) market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Lyophilization Contract Manufacturing Services (CDMO) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For United States market, this report focuses on the Lyophilization Contract Manufacturing Services (CDMO) market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in United States.
By Company
Thermo Fisher Scientific Inc.
Ascendia Pharmaceuticals
PCI Pharma Services
Ellab
Lyophilization Technology,Inc.
Lundbeck
LSNE Contract Manufacturing
Pfizer
Jubilant Pharmova
CARBOGEN AMCIS
Lubrizol Life Science
Recipharm AB
Berkshire Sterile Manufacturing
AbbVie
Zenvision Pharma LLP
Eurofins
COC Farmaceutici
Leadgene Biomedical,Inc.
Liof Pharma
Argonaut Manufacturing Services
Societal CDMO
PharmTech
Oakwood Labs
IDT Biologika
EMCM
Segment by Type
Formulation&Process Development
Lyophilization
Clinical Supply Manufacturing
Commercial Manufacturing
Storage&Distribution
Analytical Services
Segment by Application
Pharmaceutical Company
Biotechnology Company
Generic Company
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter Introduction
Chapter 1Introduces Lyophilization Contract Manufacturing Services (CDMO) definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Lyophilization Contract Manufacturing Services (CDMO) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Lyophilization Contract Manufacturing Services (CDMO) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lyophilization Contract Manufacturing Services (CDMO) revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices